瑞典全国性研究:CKD患者严重精神疾病患病率及其与健康结局的关联
该瑞典全国性研究纳入2008-2020年32,943例新发CKD G3b-5期或接受肾脏替代治疗的患者,估计严重精神疾病(SMI)患病率为7.3%,较一般人群高56%。在30,103例未接受KRT的患者中,所有SMI均与更高死亡率相关,双相障碍还与更快的eGFR下降相关,而精神分裂症和双相障碍患者启动KRT率较低。
要点
- CKD患者SMI总体患病率为7.3%,其中重度抑郁5.6%、双相2.1%、精神分裂症0.5%。
- 所有三种SMI均与CKD患者死亡率升高相关。
- 双相障碍与更快的eGFR下降相关,精神分裂症和双相障碍与较低KRT启动率相关。
核心结论
- CKD患者SMI患病率高于一般人群,且SMI与死亡率升高相关。
- 双相障碍与更快的eGFR下降相关,精神分裂症和双相障碍患者启动KRT率较低。
研究设计与样本
- 瑞典全国性横断面和队列研究,使用瑞典肾脏登记系统。
- 纳入2008-2020年32,943例新发CKD G3b-5期或KRT患者估计SMI患病率。
- 其中30,103例未接受KRT患者用于分析SMI与后续健康结局的关联。
主要发现
- CKD患者SMI总体患病率为7.3%,较一般人群高56%。
- 精神分裂症、双相障碍、重度抑郁患病率分别为0.5%、2.1%、5.6%。
- 精神分裂症与30% eGFR下降无关(HR 0.92 [95%CI 0.65-1.29]),但与较低KRT启动率相关(HR 0.56 [95%CI 0.39-0.80])。
- 双相障碍与较高30% eGFR下降率相关(HR 1.47 [95%CI 1.29-1.67]),与较低KRT启动率相关(HR 0.79 [95%CI 0.67-0.94])。
- 重度抑郁与30% eGFR下降或KRT启动无关。
临床怎么用
- 肾内科医生应关注CKD患者SMI的筛查与管理,尤其双相障碍患者需监测肾功能下降。
- 对合并精神分裂症或双相障碍的CKD患者,需注意其KRT启动率可能较低。
局限性
- 缺乏初级保健数据。
- 排除了CKD G1-3a期患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Patients with chronic kidney disease (CKD) often face mental health problems, but the burden of severe mental illness (SMI) in this population is unclear. We estimated the prevalence of SMIs among people with CKD and their associations with health outcomes. STUDY DESIGN: Nationwide cross-sectional and cohort study. SETTING & PARTICIPANTS: Using the Swedish Renal Registry, we identified 32,943 patients with incident CKD G3b-5 or kidney replacement therapy (KRT) between 2008 and 2020 for estimation of the prevalence of SMIs. Data about the 30,103 patients not receiving KRT were used to examine associations between SMIs and subsequent health outcomes. EXPOSURE: Occurrence of SMIs (ie, schizophrenia, bipolar disorder, and major depressive disorder) before the date of first registration into the registry (index date), using diagnoses from inpatient or specialist outpatient care. OUTCOME: 30% decline in eGFR, initiation of KRT, and all-cause mortality. ANALYTICAL APPROACH: Prevalence of SMIs was estimated in patients with CKD and compared with the general population using standardization with ratios adjusted for age, sex, and calendar year. Associations between SMIs and health outcomes were examined using Cox proportional hazards models. RESULTS: The overall prevalence of SMI was 7.3% in patients with CKD, which was 56% higher than the general population. The prevalences for schizophrenia, bipolar disorder, and major depressive disorder were 0.5%, 2.1%, and 5.6%, respectively. All 3 SMIs were associated with a higher mortality rate. Schizophrenia was not associated with 30% decline in eGFR (HR, 0.92 [95% CI, 0.65-1.29]), but it was associated with a lower rate of initiating KRT (HR, 0.56 [95% CI, 0.39-0.80]). Bipolar disorder was associated with a higher rate of 30% decline in eGFR (HR, 1.47 [95% CI, 1.29-1.67]) but a lower rate of initiating KRT (HR, 0.79 [95% CI, 0.67-0.94]). Major depressive disorder was not associated with 30% decline in eGFR or initiation of KRT. LIMITATIONS: Lack of primary care data and exclusion of individuals with CKD G1-3a. CONCLUSIONS: Patients with CKD had a higher prevalence of SMI compared with the general population. In patients with CKD, each SMI was associated with higher mortality, and bipolar disorder was associated with a faster eGFR decline. Patients with CKD and pre-existing schizophrenia or bipolar disorder experienced a lower rate of initiating KRT. PLAIN-LANGUAGE SUMMARY: Patients with chronic kidney disease (CKD) frequently experience mental health problems, yet the prevalence and impact of severe mental illness (SMI) in this population remain uncertain. This Swedish nationwide study revealed that the prevalence of any SMI was 7.3% among patients with CKD (0.5% for schizophrenia, 2.1% for bipolar disorder, and 5.6% for major depressive disorder), representing a 56% higher prevalence than experienced by the Swedish general population. All 3 SMIs were associated with a higher mortality rate in patients with CKD, and bipolar disorder was also associated with a faster eGFR decline. Moreover, patients with CKD and schizophrenia or bipolar disorder exhibited a lower rate of initiating kidney replacement therapy. These findings highlight the need for improved recognition and management of SMI among people with kidney disease.
引用
- Zhu N, Faucon AL, Kuja-Halkola R, et al. Prevalence of Severe Mental Illness and Its Associations With Health Outcomes in Patients With CKD: A Swedish Nationwide Study. Am J Kidney Dis. 2025. PMID: 40010484. doi:10.1053/j.ajkd.2024.12.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。